EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+29.65%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$55.8M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Top Buys
| 1 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
+$3.5M |
| 2 |
Weibo
WB
|
+$2.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.88M |
| 4 |
Deckers Outdoor
DECK
|
+$1.72M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1.55M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
+$20.3M |
| 2 |
Yum China
YUMC
|
+$12.8M |
| 3 |
Pinduoduo
PDD
|
+$10.6M |
| 4 |
TSMC
TSM
|
+$9.64M |
| 5 |
Apple
AAPL
|
+$4.98M |
Sector Composition
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Linde
LIN
$223B
| $315K | 0.02% |
766
+4
| +0.5% | +$1.64K |
|
|
MORF
227
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $314K | 0.02% |
+10,888
| New | +$314K |
|
228
BioCryst Pharmaceuticals
BCRX
$1.72B
| $307K | 0.02% |
51,317
+9,820
| +24% | +$58.8K |
|
229
Dollar Tree
DLTR
$20.3B
| $307K | 0.02% |
2,158
-245
| -10% | -$34.8K |
|
230
Rhythm Pharmaceuticals
RYTM
$6.63B
| $300K | 0.02% |
+6,533
| New | +$300K |
|
231
Medtronic
MDT
$119B
| $298K | 0.02% |
3,617
+434
| +14% | +$35.8K |
|
232
Zentalis Pharmaceuticals
ZNTL
$118M
| $293K | 0.02% |
19,340
+9,033
| +88% | +$137K |
|
233
Elevance Health
ELV
$69.4B
| $292K | 0.02% |
620
+55
| +10% | +$25.9K |
|
234
CVS Health
CVS
$89.1B
| $289K | 0.02% |
3,658
+313
| +9% | +$24.7K |
|
235
Bristol-Myers Squibb
BMY
$95.1B
| $288K | 0.02% |
5,619
+902
| +19% | +$46.3K |
|
236
Stryker
SYK
$150B
| $287K | 0.02% |
957
+124
| +15% | +$37.1K |
|
237
GlobalFoundries
GFS
$18.3B
| $286K | 0.02% |
4,714
-453
| -9% | -$27.5K |
|
238
Cigna
CI
$80.3B
| $285K | 0.02% |
953
+176
| +23% | +$52.7K |
|
|
SWTX
239
DELISTED
SpringWorks Therapeutics
SWTX
| $283K | 0.02% |
7,752
-1,474
| -16% | -$53.8K |
|
240
Zscaler
ZS
$43.8B
| $283K | 0.02% |
1,277
-100
| -7% | -$22.2K |
|
241
Wells Fargo
WFC
$254B
| $282K | 0.02% |
5,731
+21
| +0.4% | +$1.03K |
|
242
Zoetis
ZTS
$67.3B
| $277K | 0.02% |
1,403
+207
| +17% | +$40.9K |
|
243
Diamondback Energy
FANG
$39.7B
| $277K | 0.02% |
1,783
-184
| -9% | -$28.5K |
|
244
Trade Desk
TTD
$25.4B
| $276K | 0.02% |
3,841
-368
| -9% | -$26.5K |
|
245
Warner Bros
WBD
$30.6B
| $273K | 0.02% |
23,983
-2,472
| -9% | -$28.1K |
|
246
89bio
ETNB
$1.27B
| $272K | 0.02% |
24,363
+4,742
| +24% | +$53K |
|
247
Take-Two Interactive
TTWO
$45.9B
| $270K | 0.02% |
+1,678
| New | +$270K |
|
248
Boston Scientific
BSX
$160B
| $266K | 0.02% |
4,607
+683
| +17% | +$39.5K |
|
249
Las Vegas Sands
LVS
$36.9B
| $263K | 0.02% |
+5,345
| New | +$263K |
|
250
Coca-Cola Europacific Partners
CCEP
$40.9B
| $262K | 0.02% |
+3,932
| New | +$262K |
|